Cellectricon to discuss phenotypic assay designs for chronic pain research in webinar

Cellectricon explores novel phenotypic assay designs in a webinar, 5 September, 11am-12pm (EDT)

Cellectricon, a leading provider of advanced cell-based screening technologies and services, invites researchers to join the webinar entitled “Phenotypic Screening Strategies for Chronic Pain Research”, taking place on 5 September, 11:00 am to 12:00pm EDT. Investigating the latest approaches to phenotypic assay designs for drug discovery in chronic pain research, the webinar will explain how researchers can enhance neurobiology workflows using Cellectricon’s comprehensive phenotypic screening platform and highly relevant disease models. 

Dr Paul Karila (Head of Discovery Services, Cellectricon), and Dr Charlotta Blom (Senior Researcher, Cellectricon) will talk the viewers through the many benefits of using phenotypic assays for drug discovery in the treatment of chronic pain. Viewers will learn how to increase the chance of identifying modulators of a disease, even without information on the target. Furthermore, by focusing on downstream functional responses such as neuronal excitability, identifying novel mechanisms as well as compounds acting on the pain pathway is now possible.   

The webinar presents an ideal opportunity for researchers and lab managers to keep up to date with the most recent innovations in areas including neurobiology, translational science, drug discovery and electrophysiology. To discuss these technologies in more depth, Cellectricon will also be attending the 7th Annual Pain & Migraine Therapeutics Summit, 25-26 September in Boston (USA).

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cellectricon. (2019, June 19). Cellectricon to discuss phenotypic assay designs for chronic pain research in webinar. News-Medical. Retrieved on May 18, 2024 from https://www.news-medical.net/news/20130821/Cellectricon-to-discuss-phenotypic-assay-designs-for-chronic-pain-research-in-webinar.aspx.

  • MLA

    Cellectricon. "Cellectricon to discuss phenotypic assay designs for chronic pain research in webinar". News-Medical. 18 May 2024. <https://www.news-medical.net/news/20130821/Cellectricon-to-discuss-phenotypic-assay-designs-for-chronic-pain-research-in-webinar.aspx>.

  • Chicago

    Cellectricon. "Cellectricon to discuss phenotypic assay designs for chronic pain research in webinar". News-Medical. https://www.news-medical.net/news/20130821/Cellectricon-to-discuss-phenotypic-assay-designs-for-chronic-pain-research-in-webinar.aspx. (accessed May 18, 2024).

  • Harvard

    Cellectricon. 2019. Cellectricon to discuss phenotypic assay designs for chronic pain research in webinar. News-Medical, viewed 18 May 2024, https://www.news-medical.net/news/20130821/Cellectricon-to-discuss-phenotypic-assay-designs-for-chronic-pain-research-in-webinar.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cellectricon introduces Dynaflow Resolve Temperature Control system for ion channel research